AbbVie Inc (ABBV) Actualités

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie to Present at Citi's 2024 Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Nov. 25, 2024...

Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products

Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan...

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of...

AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations

AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations PR Newswire NORTH CHICAGO...

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia PR Newswire NORTH CHICAGO, Ill., Nov. 11, 2024 EMPOWER-1 and EMPOWER-2...

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day PR Newswire IRVINE, Calif...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 (GLOBE NEWSWIRE) -- AbbVie (NYSE: ABBV) and...

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop...

Form 8-K - Current report

AbbVie Reports Third-Quarter 2024 Financial Results

AbbVie Reports Third-Quarter 2024 Financial Results PR Newswire NORTH CHICAGO, Ill., Oct. 30, 2024 Reports...

SkinSpirit joins Allergan Aesthetics in Supporting Girls Inc. and Empowering the New Generation of Women in STEM

SkinSpirit joins Allergan Aesthetics in Supporting Girls Inc. and Empowering the New Generation of Women in...

AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline

AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline PR...